Literature DB >> 28327933

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

M Dreyling, M Ghielmini, S Rule, G Salles, U Vitolo, M Ladetto.   

Abstract

Entities:  

Year:  2017        PMID： 28327933     DOI： 10.1093/annonc/mdx020

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  11 in total

1.  Interim FDG-PET in lymphoma, a questionable practice in hematology.

Authors:  Hugo J A Adams; Thomas C Kwee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-07-31       Impact factor: 9.236

2.  Indolent lymphoma with composite histology and simultaneous transformation at initial diagnosis exhibit clinical features similar to de novo diffuse large B-cell lymphoma.

Authors:  Hanno Witte; Harald Biersack; Svenja Kopelke; Dirk Rades; Hartmut Merz; Veronica Bernard; Hendrik Lehnert; Niklas Gebauer
Journal:  Oncotarget       Date:  2018-04-13

3.  Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma.

Authors:  Georg Hess; Karola Wagner; Ulrich Keller; Paul La Rosee; Johannes Atta; Kai Hübel; Christian Lerchenmueller; Daniel Schoendube; Mathias Witzens-Harig; Christian Ruckes; Christoph Medler; Christina van Oordt; Wolfram Klapper; Matthias Theobald; Martin Dreyling
Journal:  Hemasphere       Date:  2020-06-08

Review 4.  Cancer Immunotherapy and the Immune Response in Follicular Lymphoma.

Authors:  Frank Stenner; Christoph Renner
Journal:  Front Oncol       Date:  2018-06-19       Impact factor: 6.244

5.  Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma: Results of the MIR Study.

Authors:  Klaus Herfarth; Peter Borchmann; Sven Schnaidt; Karin Hohloch; Volker Budach; Marianne Engelhard; Andreas Viardot; Rita Engenhart-Cabillic; Ulrich Keller; Gabriele Reinartz; Hans-Theodor Eich; Mathias Witzens-Harig; Clemens F Hess; Bernd Dörken; Jan Dürig; Thomas Wiegel; Wolfgang Hiddemann; Eva Hoster; Christiane Pott; Martin Dreyling
Journal:  Hemasphere       Date:  2018-11-30

6.  Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study.

Authors:  Emmanuel Bachy; John F Seymour; Pierre Feugier; Fritz Offner; Armando López-Guillermo; David Belada; Luc Xerri; John V Catalano; Pauline Brice; François Lemonnier; Alejandro Martin; Olivier Casasnovas; Lars M Pedersen; Véronique Dorvaux; David Simpson; Sirpa Leppa; Jean Gabarre; Maria G da Silva; Sylvie Glaisner; Loic Ysebaert; Anne Vekhoff; Tanin Intragumtornchai; Steven Le Gouill; Andrew Lister; Jane A Estell; Gustavo Milone; Anne Sonet; Jonathan Farhi; Harald Zeuner; Hervé Tilly; Gilles Salles
Journal:  J Clin Oncol       Date:  2019-07-24       Impact factor: 44.544

7.  Partnering with general practitioners to optimize survivorship for patients with lymphoma: a phase II randomized controlled trial (the GOSPEL I trial).

Authors:  Raymond Javan Chan; Stephanie Buhagiar; Laisa Teleni; Camilla Simonsen; Jane Turner; Courtney Rawson; Nicolas H Hart; Lee Jones; Louisa Gordon; Ria Joseph; Oluwaseyifunmi Andi Agbejule; Fiona Henderson; Joel Rhee; Marissa Ryan; Christine Carrington; Sally Mapp
Journal:  Trials       Date:  2021-01-06       Impact factor: 2.279

8.  Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial.

Authors:  Sriram Balasubramanian; Brendan Hodkinson; Stephen J Schuster; Nathan H Fowler; Judith Trotman; Georg Hess; Bruce D Cheson; Michael Schaffer; Steven Sun; Sanjay Deshpande; Jessica Vermeulen; Gilles Salles; Ajay K Gopal
Journal:  Cancer Med       Date:  2021-11-17       Impact factor: 4.452

9.  Oncological outcome and recurrence pattern analysis after involved-field irradiation in combination with rituximab for early-stage nodal and extranodal follicular lymphoma.

Authors:  Laila König; Klaus Herfarth; Juliane Hörner-Rieber; Sascha Dietrich; Thomas Wiegel; Jürgen Debus; Andreas Viardot
Journal:  Strahlenther Onkol       Date:  2020-05-06       Impact factor: 3.621

10.  Repeated courses of low-dose 2 × 2 Gy radiation therapy in patients with indolent B-cell non-Hodgkin lymphomas.

Authors:  Khalil Saleh; Jean-Marie Michot; Antoine Schernberg; Julien Lazarovici; Claude Chahine; Alina Danu; Nadine Khalife-Saleh; Julien Rossignol; David Ghez; Valentine Martin; Renaud Mazeron; Christophe Fermé; Angela Boros; Vincent Ribrag; Theodore Girinsky
Journal:  Cancer Med       Date:  2020-04-06       Impact factor: 4.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.